Verenium CorporationNASDAQ
VRNM is defunct.
  • Sep. 20, 2013, 7:40 AM
    • Industrial biotech company Verenium (VRNM) +57.7% premarket after agreeing to be acquired by BASF (BASFY.PK) for ~$51.2M, or $4/share, a 59% premium to Thursday's closing price.
    • VRNM focuses on developing and selling high-performance enzymes used in food and fuel markets.
    | Sep. 20, 2013, 7:40 AM